X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (48065) 48065
Book Chapter (52) 52
Magazine Article (51) 51
Publication (18) 18
Conference Proceeding (8) 8
Book Review (6) 6
Dissertation (6) 6
Web Resource (4) 4
Book / eBook (3) 3
Newsletter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44560) 44560
remission induction (37954) 37954
female (28714) 28714
male (28401) 28401
middle aged (22542) 22542
adult (22076) 22076
aged (15328) 15328
treatment outcome (13092) 13092
oncology (11227) 11227
antineoplastic combined chemotherapy protocols - therapeutic use (10512) 10512
hematology (9568) 9568
adolescent (9555) 9555
remission (7395) 7395
prognosis (6585) 6585
follow-up studies (6357) 6357
child (6189) 6189
chemotherapy (5831) 5831
therapy (5796) 5796
combined modality therapy (5720) 5720
retrospective studies (5525) 5525
recurrence (5319) 5319
time factors (5248) 5248
cancer (4370) 4370
aged, 80 and over (4267) 4267
survival rate (4136) 4136
young adult (3988) 3988
child, preschool (3860) 3860
disease-free survival (3686) 3686
care and treatment (3564) 3564
antineoplastic agents - therapeutic use (3176) 3176
transplantation (3139) 3139
prospective studies (2985) 2985
gastroenterology & hepatology (2967) 2967
drug administration schedule (2955) 2955
survival analysis (2903) 2903
neoplasm staging (2852) 2852
risk factors (2799) 2799
antineoplastic combined chemotherapy protocols - adverse effects (2691) 2691
medicine & public health (2571) 2571
remission induction - methods (2536) 2536
rheumatology (2512) 2512
children (2500) 2500
patients (2479) 2479
infant (2427) 2427
surgery (2424) 2424
survival (2412) 2412
leukemia (2403) 2403
drug therapy, combination (2355) 2355
cyclophosphamide - administration & dosage (2346) 2346
severity of illness index (2259) 2259
antineoplastic combined chemotherapy protocols - administration & dosage (2227) 2227
immunology (2180) 2180
pediatrics (2160) 2160
immunosuppressive agents - therapeutic use (2152) 2152
medicine, general & internal (2141) 2141
analysis (2138) 2138
leukemia, myeloid, acute - drug therapy (2009) 2009
disease progression (2005) 2005
cytarabine - administration & dosage (1989) 1989
doxorubicin - administration & dosage (1980) 1980
disease (1966) 1966
rituximab (1927) 1927
research (1912) 1912
vincristine - administration & dosage (1903) 1903
health aspects (1891) 1891
animals (1860) 1860
cisplatin - administration & dosage (1854) 1854
acute disease (1825) 1825
diagnosis (1825) 1825
trial (1821) 1821
hematopoietic stem cell transplantation (1816) 1816
abridged index medicus (1812) 1812
relapse (1765) 1765
management (1700) 1700
efficacy (1655) 1655
drug therapy (1594) 1594
antibodies, monoclonal - therapeutic use (1574) 1574
infliximab (1550) 1550
etoposide - administration & dosage (1549) 1549
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1534) 1534
transplantation, homologous (1533) 1533
bone marrow transplantation (1530) 1530
acute myeloid leukemia (1505) 1505
dose-response relationship, drug (1501) 1501
cyclophosphamide (1499) 1499
stem cells (1481) 1481
biopsy (1450) 1450
transplantation, autologous (1432) 1432
acute myeloid-leukemia (1429) 1429
clinical trials (1416) 1416
radiotherapy (1380) 1380
prednisone - administration & dosage (1379) 1379
acute myelogenous leukemia (1363) 1363
double-blind (1342) 1342
inflammatory-bowel-disease (1341) 1341
pharmacology & pharmacy (1330) 1330
antineoplastic agents - administration & dosage (1326) 1326
risk (1316) 1316
ulcerative colitis (1316) 1316
salvage therapy (1302) 1302
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41648) 41648
Japanese (2096) 2096
Russian (1464) 1464
Spanish (804) 804
Chinese (743) 743
French (686) 686
German (582) 582
Polish (457) 457
Italian (269) 269
Hungarian (85) 85
Dutch (73) 73
Portuguese (71) 71
Czech (51) 51
Ukrainian (49) 49
Bulgarian (44) 44
Romanian (28) 28
Korean (23) 23
Danish (22) 22
Croatian (18) 18
Serbian (17) 17
Swedish (12) 12
Hebrew (9) 9
Finnish (6) 6
Norwegian (6) 6
Slovak (6) 6
Bosnian (5) 5
Lithuanian (3) 3
Icelandic (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 20, pp. 1946 - 1960
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 18, pp. 1723 - 1736
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 8, pp. 711 - 721
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 8, pp. 699 - 710
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 5, pp. 490 - 497
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 5, pp. 417 - 427
.... 1 , 2 For nearly four decades, cyclophosphamide and glucocorticoids have been the standard therapy for the induction of remission... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | MEDICINE, GENERAL & INTERNAL | ACTIVATION | SPECIFICITY | PROTEINASE-3 | LYMPHOCYTES | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 16, pp. 1519 - 1528
Journal Article